ClinicalTrials.gg
CompletedNCT06531746Updated May 19, 2026

Effect of Extracorporeal Shock Wave on Electrophysiological Changes and Pain in Patients With Lower Cross Syndrome

An interventional study of Extracorporeal shock wave and Conventional physical therapy program in Lower Cross Syndrome, sponsored by Ahmed Alshimy. Completed at 1 site in Egypt. Open to participants aged 30 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Ahmed Alshimy · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
30 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 299 studies in Pain with a site in Egypt — 65 open to participants now, 80 under way, 5 of them phase 3. Pain · Egypt.

Enrollment
228th of 285
40 · median 62
Started
2025
with 38 others
No phase
189 of 299
52 open now
Registered
196th of 299
by date

Among the 299 studies in Pain with a site in Egypt, this one is the 228th largest by enrollment of the 285 interventional ones that give a count, is one of 39 that started in 2025, is one of 189 with no phase, and was the 196th registered.

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 40 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Open to participants now

65 of the 299 studies in Pain with a site in Egypt are open now, in 1 country. Each count lists the studies.

All 65 open studies →

Who these studies take

Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.

This study: 30 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 299 studies in Pain with a site in Egypt, or all of them as a file.
02

Study summary

Lower Cross Syndrome happens when there is muscular imbalance between weak and tight muscles. The tight muscles are generally the hip flexors and erector spinae, and weak muscles are the abdominals and gluteal muscles. Shortening occurs in the hip flexors while weakening occurs in the abdominals and gluteal muscles.

Read the detailed description

Group I (Study): will consist of 20 patients with lower cross syndrome and will receive extracorporeal shock wave in addition to conventional physical therapy program. For 12 sessions every other day, each session for 1 hour.

Group II (Control): will consist of 20 patients with lower cross syndrome and will receive sham extracorporeal shock wave in addition to conventional physical therapy program only same as group (I). For 12 sessions every other day, each session for 1 hour.

03

Conditions studied

  • Lower Cross Syndrome

Browse trials for

Keywords

  • Extracorporeal Shock Wave
  • Electrophysiological changes
  • Pain
  • Lower Cross Syndrome
04

Who can participate

Ages eligible
30 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Forty-four lower cross syndrome patients from both genders their ages ranged from 30-45 years old.
  2. All patients in present study will be ambulant independently.
  3. All patients will be medically stable.
  4. The (BMI) will be ranged from 20:25 Kg/m2.

Exclusion criteria

Exclusion Criteria:

  1. Patients with musculoskeletal deformities and disorders.
  2. Patients with psychiatric disorders or seizures.
  3. Patients with visual and auditory impairment or tremors influencing balance.
  4. Patients with other neuromuscular disorders.
  5. Patients with more than 25 kg/m2.
  6. Patients with cognitive impairment.
  7. Patients with lower limb or head and brain surgeries.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Study group (I)

    Will consist of 20 patients with lower cross syndrome and will receive extracorporeal shock wave in addition to conventional physical therapy program. For 12 sessions every other day, each session for 1 hour.

    Other: Extracorporeal shock wave · Other: Conventional physical therapy program

  • Experimental
    Control group (II)

    Will consist of 20 patients with lower cross syndrome and will receive sham extracorporeal shock wave in addition to conventional physical therapy program only same as group (I). For 12 sessions every other day, each session for 1 hour.

    Other: Conventional physical therapy program · Device: Sham (No Treatment)

Interventions

  • OtherExtracorporeal shock wave

    Participants will receive (2.5 bars, 2000 pulses, 5 Hz, 7 min) rESWT with 1500 shock targeting the taut band of erector spinae, and 500 around the taut band, by using an EME S.r.l. via Degli Abeti 88/161122 Pesaro \[serial number: EM12681015\], Italy, shock wave generator.

  • OtherConventional physical therapy program

    Stretching and strengthening of Iliopoas muscle and Stretching and strengthening of Lower back muscles

  • DeviceSham (No Treatment)

    Sham extracorporeal shock wave will be introduced without real shock wave impulses.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    Assess pain intensity

    Time frame: 4 weeks

  2. Electromyograph

    Assess activity of lower back muscles (Erector Spinae)

    Time frame: 4 weeks

07

Study locations

1 site
  • Al Ryada University for Science and Technology
    Sadat, Menoufia, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in Nov 2025, 9 months.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 9 months is close to that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2024
First posted
Aug 1, 2024
StartActual
Feb 2, 2025
Primary completionActual
Nov 28, 2025
CompletionActual
Nov 29, 2025
Last update
May 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06531746
Lead sponsor
Ahmed Alshimy
Responsible party
Ahmed Alshimy (Lecturer of Physical Therapy for Neurology and its Surgery Faculty of Physical Therapy - Al Ryada University for Science and Technology, AlRyada University for Science & Technology) — Sponsor-investigator
First posted
Aug 1, 2024
Start date
Feb 2, 2025
Primary completion
Nov 28, 2025
Completion
Nov 29, 2025
Last update
May 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion